Back

A RHNO1-ATR/Chk1 positive feedback loop sustains the DNA replication stress response

Jirapongwattana, N.; Trujillo Jaramillo, C.; Conover, C. M.; Chiruvella, K. K.; Her, J.; Ghosal, G.; Bunting, S. F.; Ramsden, D. A.; Karpf, A. R.

2026-05-24 cancer biology
10.64898/2026.05.22.727300 bioRxiv
Show abstract

Elevated DNA replication stress is a common feature of cancer cells, rendering them dependent on ATR/Chk1 signaling, which controls the DNA replication stress checkpoint, for survival. Although the activation of ATR/Chk1 signaling is well-established, how this signal is maintained until replication stress is fully resolved is less understood. Here, we investigated the roles of RAD9-HUS1-RAD1 interacting nuclear orphan 1 (RHNO1) in cancer progression and its involvement in maintaining ATR/Chk1 signaling during the DNA replication stress response. We demonstrate that depletion of RHNO1 significantly inhibits cancer cell proliferation in vitro and tumor growth in vivo. Mechanistically, we show that, while RHNO1 is dispensable for initial ATR/Chk1 signal activation, it is upregulated and stabilized following replication stress. RHNO1 is required to sustain ATR/Chk1 signaling, prevent premature checkpoint collapse, and suppress genomic instability. Under basal conditions, RHNO1 is rapidly degraded by the proteasome, however, RHNO1 is phosphorylated and stabilized following DNA replication stress. Stabilization of RHNO1 is mediated by ATR/Chk1 signaling which promotes RHNO1 localization to stressed replication forks marked by phosphorylated RPA32. Together, our data reveals a novel positive feedback loop wherein ATR/Chk1 signaling activation stabilizes RHNO1, which, in turn, is required to sustain the signal and thus the replication stress response. This work identifies RHNO1 as a key component in the cellular replication stress response and highlights its potential as a therapeutic target for tumor cells reliant on ATR/Chk1 signaling.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Nature Communications
5641 papers in training set
Top 16%
11.3%
2
Cell Reports
1498 papers in training set
Top 2%
11.3%
3
Oncogene
85 papers in training set
Top 0.2%
8.4%
4
Molecular and Cellular Biology
47 papers in training set
Top 0.1%
6.4%
5
Nucleic Acids Research
1281 papers in training set
Top 3%
6.4%
6
eLife
5828 papers in training set
Top 23%
5.2%
7
Molecular Cell
350 papers in training set
Top 1%
5.2%
50% of probability mass above
8
Science Signaling
65 papers in training set
Top 0.2%
3.8%
9
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 16%
3.3%
10
EMBO Reports
263 papers in training set
Top 2%
3.1%
11
The EMBO Journal
309 papers in training set
Top 2%
3.1%
12
PLOS Genetics
862 papers in training set
Top 5%
2.5%
13
Molecular Cancer Research
49 papers in training set
Top 0.4%
2.5%
14
Science Advances
1243 papers in training set
Top 14%
2.5%
15
Journal of Biological Chemistry
690 papers in training set
Top 6%
1.6%
16
Scientific Reports
3612 papers in training set
Top 58%
1.6%
17
Cell Death & Disease
21 papers in training set
Top 0.3%
1.4%
18
Communications Biology
993 papers in training set
Top 20%
1.3%
19
Nature Cell Biology
118 papers in training set
Top 3%
1.1%
20
PLOS ONE
5266 papers in training set
Top 58%
1.0%
21
Cancer Research
130 papers in training set
Top 3%
1.0%
22
Journal of Cell Biology
392 papers in training set
Top 4%
1.0%
23
Cell Death Discovery
58 papers in training set
Top 2%
0.8%
24
NAR Cancer
37 papers in training set
Top 0.8%
0.8%
25
iScience
1154 papers in training set
Top 42%
0.6%
26
Journal of Cell Science
393 papers in training set
Top 5%
0.6%
27
Cancer Research Communications
51 papers in training set
Top 2%
0.6%
28
DNA Repair
19 papers in training set
Top 0.3%
0.6%
29
Developmental Cell
196 papers in training set
Top 5%
0.6%
30
Nature
645 papers in training set
Top 12%
0.6%